These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 20524682

  • 1. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone).
    Paudel A, Van Humbeeck J, Van den Mooter G.
    Mol Pharm; 2010 Aug 02; 7(4):1133-48. PubMed ID: 20524682
    [Abstract] [Full Text] [Related]

  • 2. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A, Nies E, Van den Mooter G.
    Mol Pharm; 2012 Nov 05; 9(11):3301-17. PubMed ID: 23009610
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ, Hinrichs WL, Visser MR, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):220-9. PubMed ID: 16427226
    [Abstract] [Full Text] [Related]

  • 4. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen-PVP K25.
    Ayenew Z, Paudel A, Van den Mooter G.
    Eur J Pharm Biopharm; 2012 May 09; 81(1):207-13. PubMed ID: 22293573
    [Abstract] [Full Text] [Related]

  • 5. Drug-polymer miscibility across a spray dryer: a case study of naproxen and miconazole solid dispersions.
    Worku ZA, Aarts J, Singh A, Van den Mooter G.
    Mol Pharm; 2014 Apr 07; 11(4):1094-101. PubMed ID: 24533891
    [Abstract] [Full Text] [Related]

  • 6. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Apr 07; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 8. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S, Cathcart H, O'Reilly NJ.
    Eur J Pharm Biopharm; 2016 Oct 04; 107():16-31. PubMed ID: 27378287
    [Abstract] [Full Text] [Related]

  • 9. Role of molecular interaction in stability of celecoxib-PVP amorphous systems.
    Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK.
    Mol Pharm; 2005 Oct 04; 2(5):384-91. PubMed ID: 16196491
    [Abstract] [Full Text] [Related]

  • 10. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 11. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Taylor LS.
    Mol Pharm; 2010 Apr 05; 7(2):477-90. PubMed ID: 20039693
    [Abstract] [Full Text] [Related]

  • 12. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
    Paudel A, Loyson Y, Van den Mooter G.
    J Pharm Sci; 2013 Apr 05; 102(4):1249-67. PubMed ID: 23359268
    [Abstract] [Full Text] [Related]

  • 13. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F, Trivino A, Prasad D, Chauhan H.
    Eur J Pharm Sci; 2015 Apr 25; 71():12-24. PubMed ID: 25686597
    [Abstract] [Full Text] [Related]

  • 14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659
    [Abstract] [Full Text] [Related]

  • 15. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX, Anderson BD.
    J Pharm Sci; 2013 Mar 10; 102(3):876-91. PubMed ID: 23280486
    [Abstract] [Full Text] [Related]

  • 16. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.
    Paudel A, Van den Mooter G.
    Pharm Res; 2012 Jan 10; 29(1):251-70. PubMed ID: 21773852
    [Abstract] [Full Text] [Related]

  • 17. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y, Booth J, Meehan E, Jones DS, Li S, Andrews GP.
    Mol Pharm; 2013 Jan 07; 10(1):236-48. PubMed ID: 23110477
    [Abstract] [Full Text] [Related]

  • 18. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
    Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO.
    Int J Pharm; 2007 May 04; 336(1):122-32. PubMed ID: 17184938
    [Abstract] [Full Text] [Related]

  • 19. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K, Sawicki W, Kozyra A, Tajber L.
    Eur J Pharm Biopharm; 2015 Oct 04; 96():237-46. PubMed ID: 26247119
    [Abstract] [Full Text] [Related]

  • 20. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ, Shamblin SL, Taylor LS.
    Pharm Res; 2006 Oct 04; 23(10):2417-26. PubMed ID: 16933098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.